Johnson & Johnson reports a 10.5 percent increase in sales to $11.6 billion for the 3rd quarter, partly thanks to the strong sales of Vistakon contact lenses. The company's net earnings reached $2.3 billion in the quarter, up by 13 percent. Its Worldwide Medical Devices and Diagnostics division, which includes ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.